News

Forest Labs and Glenmark collaborate; Takeda and Amylin cancel obesity accord

27-12-2012

Indian drugmaker Glenmark Pharmaceuticals has entered into an agreement with Forest Laboratories (NYSE:…

AmylinBiotechnologyBristol-Myers SquibbForest LaboratoriesGlenmark PharmaceuticalsInflammatory diseasesLicensingMetabolicsmetreleptinNeurologicalPharmaceuticalpramlintideResearchTakeda Pharmaceuticals

Takeda acquires vaccine maker LigoCyte; signs multi-drug discovery deal with Advinus

05-10-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says it is to acquire privately-held US vaccine…

Advinus TherapeuticsInflammatory diseasesLicensingLigoCyteMergers & AcquisitionsMetabolicsNeurologicalPharmaceuticalTakeda PharmaceuticalsVaccines

COMPANY SPOTLIGHT

Menarini

Back to top